|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/337 | (2006.01) | ||
| C07H 19/06 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 47/24 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 9/1272 | (2013.01) | ||
| C07D 305/14 | (2006.01) | ||
| C07H 19/06 | (2006.01) | ||
| C07H 19/073 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 3397244 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16881378.0 |
| Date of filing the European patent application | 2016-12-28 | |
| (97) | Date of publication of the European application | 2018-11-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/058055 |
| Date | 2016-12-28 |
| (87) | Number | WO 2017/115301 |
| Date | 2017-07-06 |
| (30) | Number | Date | Country code |
| 201562272772 P | 2015-12-30 | US |
| (72) |
LIN, Sih-Ting , TW
TSENG, Hui-Yuan , TW
TENG, Hsin-Wei , TW
|
| (73) |
Syncore Biotechnology Co., Ltd. ,
No. 84, Zhongshan Rd.
Dongshan Township, Yilan County 26944,
TW
Cancap Pharmaceutical Ltd. , Unit 180, 13111 Vanier Place, Richmond, British Columbia, CA |
| (54) | TREATMENT OF BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL FORMULATION OF TAXANE, A NON-LIPOSOMAL FORMULATION OF TAXANE AND A FURTHER ACTIVE AGENT |
| TREATMENT OF BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL FORMULATION OF TAXANE, A NON-LIPOSOMAL FORMULATION OF TAXANE AND A FURTHER ACTIVE AGENT |